Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 |
| Upstream (Parents) |
|---|
| (<<) LOC100126583///LOC652494///IGHV4-31///IGHM///IGHG3///IGHG2///IGHG1///IGHA2///IGHA1///IGH@ → IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 |
| (<<) LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHD///IGHA1 → IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 |
| (<<) IGHV@///IGHG1///IGHA1 → IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 |
| Downstream (Children) |
|---|
| IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 → IGHM///IGHG1///IGHA1 (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 → IGHM (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 → LOC100134331///LOC100126583///LOC652128///LOC642131///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 → LOC100133862///IGHM (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 → IGLJ3 (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 → LOC100126583///LOC652494///IGHV4-31///IGHM///IGHG3///IGHG2///IGHG1///IGHA2///IGHA1///IGH@ (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 → LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHD///IGHA1 (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 → LOC642131///IGHV1OR21-1///IGHV4-31///IGHV7-81///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 → IRF4 (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 → LOC652494///IGHM (>>) |
